FDMT Stock-Based Compensation
4D Molecular Therapeutics Inc · Stock-Based Compensation
FDMT Stock-Based Compensation
Latest reported$20.41Mperiod ending
FDMT Stock-Based Comp ($256.00K → $20.41M)
Annual stock-based compensation
High-resolution chart · PNG
FDMT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 22,016,000 | |
| 26,116,000 | |
| 19,665,000 | |
| 17,121,000 | |
| 13,799,000 | |
| 4,984,000 | |
| 3,541,000 | |
| 1,377,000 | |
| 256,000 |